India will receive 60-70 million doses of the Covishield vaccine from Oxford by December, but the vaccines will hit the market in March 2021, the Serum Institute of India (SII) in Pune said, revealing its latest updates on the ongoing trial of the Astrazeneca-Oxford vaccine. Time between December and March …
Read More »
The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »
The Union Health Ministry has asked states to submit priority population lists that will receive the Covid-19 vaccine first by the end of October, Minister Harsh Vardhan said. The priority population refers to those who are at higher risk of contracting the virus than others. The government is working around …
Read More »
Amid growing concerns about the efficacy of Covid-19 vaccines in development, several participants in Moderna and Pfizer’s human trial program reported high fever, body aches, headaches, and exhaustion. However, these are common for any vaccine and are not a cause for alarm, experts have said. Here are the latest Covid-19 …
Read More »
After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »